NOVOCURE LIMITED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.11 USD | -4.62% |
|
-8.69% | -11.11% |
| Dec. 02 | HC Wainwright Adjusts NovoCure Price Target to $38 From $30, Maintains Buy Rating | MT |
| Dec. 02 | NovoCure's Shares Rise as Pancreatic Cancer Trial Meets Primary Endpoint | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.24% | -7.70% | -18.06% | +73.81% | -8.14% | +104.44% | -60.74% | -66.29% | - | 2.96B | ||
| -0.01% | +0.01% | +0.01% | +0.01% | +0.01% | +54.88% | +82.26% | +653.52% | - | 12.57B | ||
| +0.87% | +4.07% | +0.56% | +21.53% | +3.98% | -4.44% | -0.09% | +52.02% | - | 9.48B | ||
| +1.69% | -3.68% | -6.00% | +17.74% | +0.16% | +39.93% | -30.34% | +0.35% | +521.74% | 8.86B | ||
| -0.70% | -2.15% | -3.80% | -6.20% | -6.28% | -0.15% | +0.50% | +64.74% | +115.71% | 4.67B | ||
| -0.03% | +22.06% | +42.72% | +89.81% | +55.42% | +37.15% | -1.78% | - | - | 4.64B | ||
| +0.64% | +2.36% | +8.42% | -9.89% | +3.94% | -15.34% | -43.30% | +4.89% | +13.67% | 4.52B | ||
| +0.07% | -7.85% | -7.64% | -9.62% | -9.47% | +31.91% | +107.87% | - | - | 4.46B | ||
| -0.69% | -0.61% | -0.36% | -1.14% | -2.64% | -16.95% | +15.26% | -24.00% | +225.19% | 4.35B | ||
| +1.34% | -2.08% | -15.18% | -10.36% | -6.70% | -37.00% | -63.89% | - | - | 1.27B | ||
| +1.21% | -4.00% | -9.02% | -20.01% | +0.19% | -29.83% | -51.59% | - | - | 1.23B | ||
| +1.61% | +2.36% | +4.74% | +44.00% | +7.16% | +41.50% | -20.64% | +142.33% | +3,907.69% | 1.22B | ||
| -1.68% | +12.11% | +3.12% | -7.89% | +10.32% | +22.42% | -31.87% | - | - | 969M | ||
| -1.57% | +14.94% | +20.94% | +23.61% | +15.76% | -14.71% | -27.48% | -26.19% | - | 681M | ||
| +1.71% | +0.93% | -10.73% | +4.69% | -7.36% | +5.37% | -24.36% | - | - | 665M | ||
| +2.03% | +7.32% | +11.47% | +58.94% | +12.37% | -34.12% | -59.14% | - | - | 521M | ||
| +5.51% | -10.59% | -21.54% | +91.92% | -2.41% | +14.91% | -35.73% | +5.40% | +1,717.24% | 488M | ||
| +2.70% | -1.83% | -3.99% | +21.47% | +0.41% | +20.36% | -5.18% | -72.70% | - | 413M | ||
| -.--% | -.--% | - | - | - | - | - | - | - | 380M | ||
| -0.04% | -2.78% | -0.66% | -14.75% | -2.22% | -21.43% | - | - | - | 376M | ||
| Average | +0.68% | +1.55% | -0.26% | +19.35% | +3.39% | +10.47% | -13.90% | +66.73% | +1,083.54% | 3.24B | |
| Weighted average by Cap. | +0.38% | +1.55% | +0.95% | +15.26% | +3.55% | +22.59% | +10.06% | +176.48% | +489.62% |
- Stock Market
- Equities
- NVCR Stock
- Sector NovoCure Limited